The new ISA, ISSAM, EAU, EAA and ASA recommendations on the investigation, treatment and monitoring of late-onset hypogonadism in males provide updated evidence-based information for clinicians who diagnose and treat patients with adult onset, age related testosterone deficiency
Male Hypogonadism is the condition diagnosed in men with signs and symptoms of testosterone deficien...
INTRODUCTION Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, ch...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...
The new ISA, ISSAM, EAU, EAA and ASA recommendations on the investigation, treatment and monitoring ...
C. Wang, E. Nieschlag, R. Swerdloff, H. M. Behre, W. J. Hellstrom, L. J. Gooren, J. M. Kaufman, J.-J...
Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism (LOH) in men w...
BACKGROUND: Evidence regarding functional hypogonadism, previously referred to as 'late-onset' hypog...
To provide the evidence-based recommendations on the role of testosterone (T) on age-related symptom...
The relative proportional increase of the elderly population within many countries will become one o...
Introduction: As the world population grows older late-onset hypogonadism is becoming a major health...
Male osteoporosis is now a well-recognized medical disorder with established clinical guidelines for...
The use of testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) is increasing ev...
Hypogonadism or Testosterone Deficiency (TD) in adult men as defined by low levels of serum testoste...
Adult-onset hypogonadism is a syndrome often underdiagnosed, undertreated, or incompletely explored....
In these clinical practice guidelines, specific recom-mendations are made for determining the most e...
Male Hypogonadism is the condition diagnosed in men with signs and symptoms of testosterone deficien...
INTRODUCTION Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, ch...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...
The new ISA, ISSAM, EAU, EAA and ASA recommendations on the investigation, treatment and monitoring ...
C. Wang, E. Nieschlag, R. Swerdloff, H. M. Behre, W. J. Hellstrom, L. J. Gooren, J. M. Kaufman, J.-J...
Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism (LOH) in men w...
BACKGROUND: Evidence regarding functional hypogonadism, previously referred to as 'late-onset' hypog...
To provide the evidence-based recommendations on the role of testosterone (T) on age-related symptom...
The relative proportional increase of the elderly population within many countries will become one o...
Introduction: As the world population grows older late-onset hypogonadism is becoming a major health...
Male osteoporosis is now a well-recognized medical disorder with established clinical guidelines for...
The use of testosterone replacement therapy (TRT) for late-onset hypogonadism (LOH) is increasing ev...
Hypogonadism or Testosterone Deficiency (TD) in adult men as defined by low levels of serum testoste...
Adult-onset hypogonadism is a syndrome often underdiagnosed, undertreated, or incompletely explored....
In these clinical practice guidelines, specific recom-mendations are made for determining the most e...
Male Hypogonadism is the condition diagnosed in men with signs and symptoms of testosterone deficien...
INTRODUCTION Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, ch...
We developed clinical practice guidelines to assess the individual risk-benefit profile of androgen ...